Abiopharma

New SEC Form for ResMed Inc.

New SEC Form for ResMed Inc.

Lilly to present data from two positive Phase 3 studies of Jaypirca (pirtobrutinib) in chronic lymphocytic leukemia at the 2025 American Society of Hematology (ASH) Annual Meeting

New SEC Form for ResMed Inc.

New SEC Form for ResMed Inc.

New SEC Form for ResMed Inc.

New SEC Form for ResMed Inc.

From Data to Impact: Advancing Equity and Experience in Pediatric Care | NRC Health Webcast

New SEC Form for ResMed Inc.

New SEC Form for ResMed Inc.